Sensars
Lausanne, CH · 1 known investors
Find your way into Sensars
523 people in our graph share verified history with the Sensars team — schools, employers, funds. One of them is your warm intro.
Assaf Arakiunlockedknows Guy Siman · together at Ben-Gurion University of the Negev (overlapped)
knows the team · via Imperial College London
×2knows the team · via MIT Sloan School of Management
×7knows the team · via Health Wildcatters
knows the team · via University of Rome Tor Vergata
Sensars develops an implantable neurostimulation system that restores sensory feedback to the limbs by interfacing a proprietary intra-nerve electrode array with sensory nerve fibers, paired with wearable sensor insoles. The technology targets diabetic neuropathy and limb loss to reduce complications such as ulcers, falls, and amputations.
Founders & leadership
FM
Francesco M PetriniinCo-founder and CEO of Sensars, a neurotechnology company developing implantable nerve interfaces to restore sensory feedback in limbs. Petrini holds research and development experience from EPFL, ETH Zurich, and Imperial College London, with 15+ years of work in neuroprosthetics and neuromodulation, and has authored numerous peer-reviewed publications in neuroscience and biomedical engineering.
GS
TE
Todd E. HauserCFO
Investors · 1
Competitors · 3
by search overlap
Senseneuro4 shared keywordsSense Neuro Diagnostics is developing non-invasive technology to rapidly detect stroke subtype and traumatic brain injury and to continuously monitor brain injury, producing a scan in 2.5 seconds that analyzes the entire cranial vault. Its investigational device, NeuroHawk, is intended for medical personnel and is pending FDA De Novo review.
RxFunction3 shared keywordsRxFunction develops Walkasins, a wearable lower limb sensory prosthesis that replaces lost nerve function for detecting and signaling foot pressure. It is intended for patients with peripheral neuropathy who have gait and balance impairments and are at high risk of falls.
Neuspera Medical, Inc.3 shared keywordsNeuspera Medical develops an integrated sacral neuromodulation (iSNM) system that implants a smart neurostimulator near the sacral nerve to treat urinary urge incontinence, a symptom of overactive bladder. Its device is powered by a discreet, wirelessly charged external battery worn daily, targeting patients—particularly women in the U.S.—affected by these conditions.
Companies competing with Sensars for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Sensars do?
- Sensars develops an implantable neurostimulation system that restores sensory feedback to the limbs by interfacing a proprietary intra-nerve electrode array with sensory nerve fibers, paired with wearable sensor insoles. The technology targets diabetic neuropathy and limb loss to reduce complications such as ulcers, falls, and amputations.
- Who founded Sensars?
- Sensars was founded by Francesco M Petrini, Guy Siman.
- Who are Sensars's investors?
- Sensars's investors include Health Wildcatters.
- Where is Sensars headquartered?
- Sensars is headquartered in Lausanne, CH.